GopalAnjaneyaRamarajuMD

PubMed

• The Rochester Protocol for Living Donor Liver Transplantation of Unresectable Colorectal Liver Metastasis: A 5-Year Report on Selection, Approval, and Outcomes.
  Matthew M Byrne, Mariana Chávez-Villa, Luis I Ruffolo, Anthony Loria, Yutaka Endo
  American Journal of Transplantation. 2024-09-25
• 2 citations
  Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis.
  Alexander Kusnik, Amulya Penmetsa, Farooq Chaudhary, Keerthi Renjith, Gopal Ramaraju
  Gastroenterology Research. 2024-04-01
• 2 citations
  A Case of a Beta-Catenin-Activated Hepatic Adenoma in a Male Patient With Familial Adenomatous Polyposis.
  Alexander Kusnik, Shifan Li, Elliot Graziano, Roula Katerji, Gopal Ramaraju
  ACG Case Reports Journal. 2023-03-01

Journal Articles

• Pretreatment or Resuscitation with a Lipid Infusion Shifts the Dose - Response to Bupivacaine-Induced Asytole in Rats.  
  Guy L. Weinberg, M.D., Timothy VadeBoncouer, M.D., Gopal A. Ramaraju, M.D., Marcelo F. Garcia-Amaro, M.D., Michael J. Cwik, Ph.D., Anesthesiology, V. 88, No. 4, 1071-1075
• Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells.  
  Chou HS, Hsieh CC, Charles R, Wang L, Wagner T, Fung JJ, Qian S, Lu LL, Transplantation
• Elevated catecholamines and hepatic artery vasospasm in porcine small-for-size liver graft.  
  Zhu X, Fung JJ, Nakagawa S, Wang LF, Irefin S, Cocieru A, Quintini C, Diago T, Shiba H, Parra-Sanchez I, Kelly DM, J Surg Res. 1;174(1):157-65
• Predicting discharge status following liver transplantation at a single center: A new approach for a new era.  
  Kelly DM, Bennett R, Brown N, McCoy J, Boerner D, Yu C, Eghtesad B, Barsoum W, Fung JJ, Kattan MW, Liver Tramspl
• Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis.  
  Tu Z, Li Y, Smith D, Doller C, Sugita S, Chan CC, Qian S, Fung J, Caspi RR, Lu L, Lin F, Invest Ophthalmol Vis Sci 53:959-66
• Incentives for organ donation: proposed standards for an internationally acceptable system.  
  Matas AJ, Satel S, Munn S, Richards JR, Tan-Alora A, Ambagtsheer FJ, Asis MF, Baloloy L, Cole E, Crippin J, Cronin D, Daar AS, Eason J, Fine R, Florman S, Freeman R, F..., Am J Transplant 12:306-12
• Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis.  
  Sourianarayanane A, El-Gazzaz G, Sanabria JR, Menon KV, Quintini C, Hashimoto K, Kelly D, Eghtesad B, Miller C, Fung J, Aucejo F, HPB 14(5):325-32
• Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis.  
  Tu Z, Li Q, Chou HS, Hsieh CC, Meyerson H, Peters MG, Bu H, Fung JJ, Qian S, Lu L, Lin F, Immunobiology; 216:528-34
• Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice.  
  Chou HS, Hsieh CC, Yang HR, Wang L, Arakawa Y, Brown K, Wu Q, Lin F, Peters M, Fung JJ, Lu L, Qian S, Hepatology; 53:1007-19
• Glucose balance of porcine liver allograft is an important predictor of outcome.  
  Shiba H, Zhu X, Arakawa Y, Irefin S, Wang B, Trenti L, Sanchez IP, Fung JJ, Kelly DM, J Surg Res; 171(2):851-8
• Combined liver-kidney transplants: allosensitization and recipient outcomes.  
  Askar M, Schold JD, Eghtesad B, Flechner SM, Kaplan B, Klingman L, Zein NN, Fung J, Srinivas TR, Transplantation; 91(11):1286-92
• Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation.  
  Esfeh JM, Eghtesad B, Hodgkinson P, Diago T, Fujiki M, Hashimoto K, Quintini C, Aucejo F, Kelly D, Winans C, Vogt D, Miller C, Zein N, Fung J, HPB;13(9):651-5
• Recurrence of disease following liver transplantation: Nonalcoholic steatohepatitis vs hepatitis C virus.  
  Hanouneh A, Macaron C, Lopez R, Felstein AE, Yerian L, Eghtesad B, Zein N. Recurrence, Internat J Organ Transpl Med; 2:53-61
• A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.  
  Yang HR, Hsieh CC, Wang L, Fung JJ, Lu L, Qian S, Microsurgery; 30(4):332-7
• First US near-total human face transplantation - a paradigm shift for massive complex injuries.  
  Siemionow M, Papay F, Djohan R, Bernard S, Gordon CR, Alam D, Hendrickson M, Lohman R, Eghtesad B, Fung J, Plast Reconstr Surg; 125(1):111-22
• PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft.  
  Morita M, Fujino M, Jiang G, Kitazawa Y, Xie L, Azuma M, Yagita H, Nagao S, Sugioka A, Kurosawa Y, Takahara S, Fung J, Qian S, Lu L, Li XK, Am J Transpl; 10:40–6
• IL-2 receptor antagonist is associated with rapid fibrosis progression in patients with recurrent hepatitis C after liver transplantation using serial biopsy specimens.  
  Hanouneh IA, Zein NN, Lopez N, Yerian L, Fung J, Eghtesad B, Int J Organ Transpl Med; 1:7-14
• Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.  
  Hashimoto K, Miller C, Hirose K, Diago T, Aucejo F, Quintini C, Eghtesad B, Corey R, Yerian L, Lopez R, Zein N, Fung J, Clin Transplant; 24:701-8.
• Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients?  
  Hashimoto K, Miller CM, Quintini C, Aucejo FN, Hirose K, Uso TD, Trenti L, Kelly DM, Winans CG, Vogt DP, Eghtesad B, Fung JJ, Surgery; 148:582-8
• The sleeping giant awakens - liver transplantation in China.  
  Fung J, Am J. Transplant; 10(8):1723-4
• Robotic versus laparoscopic resection of liver tumours.  
  Berber E, Akyildiz HY, Aucejo F, Gunasekaran G, Chalikonda S, Fung J, HPB; 12(8):583-6
• Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors.  
  Hashimoto K, Eghtesad B, Gunasekaran G, Fujiki M, Uso T, Quintini C, Aucejo F, Kelly D, Winans C, Vogt D, Parker B, Irefin S, Miller C, Fung J, Am J Transpl; 10:2665-72
• The role of liver stromal cells in dendritic cells development in mice.  
  Hsieh CC, Chou HS, Fung JJ, Qian S, Lu L, Transplant Proc; 42(10):4279-81
• Comparison of laparoscopic versus open liver tumor resection: a case-controlled study.  
  Tsinberg M, Telllioglu G, Simpfendorfer CH, Walsh RM, Vogt D, Fung J, Berber E, Surgery Endoscopy; 23(4):847-53
• Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27.  
  Chen Y, Jiang G, Yang HR, Gu X, Wang L, Hsieh CC, Chou HS, Fung JJ, Qian S, Lu L, J Hepatol; 51:510-9
• Join now to see all

Books/Book Chapters

• Clinical Transplantation. 
  Chapter: Hepatic and intestinal transplantation at the University of Pittsburgh 
  Page 263 - 286Abu-Elmagd K, Fung J, Reyes J, Rao A, Jain A, Mazariegos G, Marsh W, Madariaga J, Dvorchik I, Bueno J, Rogers J, McMichael J, Dodson F, Vargus H, Martin J, Slivka A, B...
• Clinical Transplants. 
  Chapter: The current status of hepatic transplantation at the University of Pittsburgh 
  Page 145 - 170Abu-Elmagd, K, Fung J, Todo S, Rao A, Reyes J, Mazariegos G, Fontes P, McMichael J, Furukawa H, Dodson F, Jain A, Pinna A, Marsh W, Marino I, Gayowski T, Doyle H, Mada...Editors: P Terasaki, F Cecka.UCLA Tissue Typing Laboratory, Los Angeles, CA

Abstracts/Posters

• Intestinal transplantation in humans.
  Reyes JD, Todo S, Tzakis AG, Abu-Elmagd K, Nour B, Casavilla A, Furukawa H, Fung JJ, Starzl TE, American College of Nutrition 1993
• Comparison of Histidine-Tryptophan-Ketoglutarate (HTK) Solution Versus University of Wisconsin (UW) Solution for Organ Preservation in Liver Transplantation.
  Eghtesad B, Broznick B, Kusum P, Malek S, Cacciarelli T, Jain A, De Vera M, Fontes P, Gayowski T, Marsh W, Marcos A, Fung JJ, Hepatology 36:A2052, American Transplant Congress, Washington, DC
• Cytokine expression by dendritic cells drives differentiation of various T cell subsets.
  Wang L, Liang X, Qian S, Bonham C, Fung J, Lu L, ASTS/AST Transplant, Chicago, IL
• Mature DC loaded with apoptotic/necrotic LCL prime specific CD4+ and CD8+ T cell responses in both EBV-memory and/or -naïve individuals.
  Metes D, Storkus W, Zeevi A, Nellis J, Logar A, Fung J, Rao A, ASTS/AST Transplant, Chicago, IL
• Hypoadrenalism syndrome in abdominal organ recipients and response to stress dose corticosteroids
  Linden P, Kramer D, Saul M, Fontes P, Abu-Elmagd K, Fung J, ASTS/AST Transplant, Chicago, IL
• Sirolimus for prophylaxis of rejection and rescue in transplanted children receiving tacrolimus
  Sindhi R, Ganjoo J, Webber S, Daugherty T, McGhee W, Cooperstone B, Holt D, Mazariegos G, Fung J, Reyes J, ASTS/AST Transplant, Chicago, IL
• The Incidence of Post-Transplant Lymphoproliferative Disorder in Children and Adults under Tacrolimus
  Jain AK, Nalesnik MA, Reyes, JD, Pokharna R, Mazariegos G, Cacciarelli TV, Eghtesad B, Fung JJ, Hepatology 36:A1998, American Association for the Study of Liver Diseases, Boston MA
• Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients
  Rao AS, Shapiro R, Jordan ML, Dvorchik I, Scantlebury V, Vivas CA, Fung JJ, Starzl TE, ASA, San Diego, CA
• Occult malignancies present at the time of transplantation.
  Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA, IAP, International Association of Pathology, Boston, MA
• Prospective study of recurrent hepatitis C: factors influencing disease severity at one year post-transplantation.
  Shakil AO, Habib S, Demetris AJ, Rabinovitz M, Saw-Stiffel T, Marcos A, Fung JJ, Hepatology Volume 40, Supplement 1: Abstract #456, American Association for the Study of Liver Diseases, Boston, MA
• Value of CMV DNA detection by polymerase chain reaction (PCR) in early diagnosis of CMV disease in small bowel allograft samples.
  Kusne S, Manez R, Abu-Elmagd K, Furukawa H, Rinaldo C, St. George K, Demetris AJ, Fung JJ, Todo S, Starzl TE, Ehrlich G, American Society of Transplant Physicians Annual Meeting, Houston, Texas
• Does colorectal cancer in patients with primary sclerosing cholangitis prohibit liver transplantation?
  Abu-Elmagd K, Iwatsuki S, Selby R, Fung JJ, Van Thiel DH, Starzl TE, Meeting of the American Gastroenterology Association and the American Association for the Study of Liver Disease, San Francisco, California
• Use of FK506 in solid organ transplantation.
  Fung JJ, Todo S, Tzakis A, Shapiro R, Selby R, Martin M, Bronsther O, Jordan M, Hakala T, McCauley J, Johnston J, Gordon R, Starzl TE, Uro-Nephrology Seminar, Paris, France
• Use of FK506 in the treatment of chronic liver allograft rejection.
  Fung JJ, Todo S, Tzakis A, Demetris A, Jain A, Abu-Elmagd K, Alessiani M, Starzl TE, The American Society of Transplant Surgeons, Chicago, Illinois
• Conversion of liver allograft recipients with cyclosporine related complications from cyclosporine to FK506.
  Fung JJ, Todo S, Jain A, McCauley J, Alessiani M, Scotti C, Starzl TE, European Society of Organ Transplantation, Barcelona, Spain
• Combined liver-kidney transplantation: Analysis of patients with preformed lymphocytotoxic antibodies.
  Fung JJ, Starzl T, Makowka L, Tzakis A, Griffin M, Duquesnoy R, International Organ Transplant Forum, Pittsburgh, Pennsylvania
• Functional characterization of lymphocytes in bronchoalveolar lavages from heart-lung transplant patients.
  Fung JJ, Zeevi A, Paradis I, Dauber J, Griffith B, Hardesty R, Duquesnoy R, Human Immunol 13:54, D. Bernard Amos Symposium in Transplantation Immunology, Durham, North Carolina
• Metabolic risk factors – influence on survival and recurrence of HCC post Liver Transplant.
  R. Kashyap, S. Safadjou, G. Connolly, S. Ramalingam, S. Agarwal, M. Vetter, L. Grinnell-Merrick, B. Maliakkal, G. Ramaraju, C. Marroquin, C. Barry, M. Orloff., International Congress of the Transplantation Society, Vancouver, Canada
• Histologic and Sex Trends of Esophageal Carcinoma in African-Americans.
  Dosunmu, H.A., Ramaraju, G.A., Olofinlade, O., Rosado, R., Adonigbagbe, O., Daniel, S.J., and Mokuolu, A.O., American College of Gastroenterology 66th Annual Scientific Meeting, Las Vegas, NV
• Virologic response to daily Interferon alpha con plus Ribavarin in chronic hepatitis c patients who have previously failed to respond to Peg Interferon alpha 2 plus Ri...
  Carroll B. Leevy, G. Ramaraju, Chris P. Chalmers, AASLD
• End of Treatment Virologic response to daily Interferon alpha con plus Ribavarin in chronic hepatitis c patients who previously failed to respond to Peg Interferon alp...
  Carroll B. Leevy, G. Ramaraju, Chris P. Chalmers, IASLD, Salvador De Bahia, Brazil
• End of Treatment Response for PEG-IFN+ Weight-Based Ribavarin No responders Retreated with IFN alfacon-1 + Weight Based Ribavarin.
  Carroll B. Leevy, G. Ramaraju, Chris P. Chalmers, American College of Gastroenterology, 69th Annual Meeting
• Interim Results of a Pilot Study of the Combination of Type1 (IFN alfacon-1) and Type2 (IFN gamma-1b) Interferon’s in Chronic Hepatitis C Patients Who Have Failed to R...
  Carroll B. Leevy, G. Ramaraju, Chris p. Chalmers, Lawrence M. Blatt, Digestive Diseases Week, Gastroenterology, 126 (suppl-2): A-126, New Orleans, LA
• Outcomes of Liver Transplantation in Combined Hepatitis-C and Hepatocellular Carcinoma Are Not Inferior to Hepatitis-C Alone.
  Raza, Ali; Ramaraju, Gopal; Rizvi, and Razack et al, AASLD, San Francisco, CA
• Effectiveness of Bridge Therapy for Hepatocellular Carcinoma Based on Explant Pathology? Single Center Experience.
  Randeep Kashyap, Saman Safadjou, Shaleen Agharwal, Saravanan Ramalingam, Leah Bryan, Pam Patzold, Benedict Maliakkal, Gopal Ramaraju, Carlos Marroquin, Cristo..., American Transplant Congress, San Diego California and ILTS 16th Annual International Congress, Hong Kong China
• Join now to see all